Disorders of sweat glands: Hyperhidrosis: Unapproved treatments

Clinics in Dermatology

Volumn 20, Issue 6, 2002, Pages 638-642

  Cheung, Jessie S ^a,b   Solomon, Barry A ^a,b,c  

^a SUNY Downstate Medical Center   (United States)

^b MEVCO Skin and Cancer Research   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALUMINUM CHLORIDE; ANTIPERSPIRANT AGENT; ATROPINE; BENZOYL PEROXIDE; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DEXTROPROPOXYPHENE; DIAZEPAM; DIHYDROERGOTOXINE MESILATE; DILTIAZEM; FLUDROCORTISONE; GLYCOPYRRONIUM BROMIDE; LIQUID NITROGEN; METHANTHELINE BROMIDE; OPIATE DERIVATIVE; OXYBUTYNIN; PERMANGANATE POTASSIUM; PHENOXYBENZAMINE; PHENTOLAMINE; PIPEROXAN; PROPANTHELINE BROMIDE; PROSTAGLANDIN E; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; UNINDEXED DRUG; XERAC AC;

ACCOMMODATION PARALYSIS; ANXIETY; BLADDER DYSFUNCTION; DERMATITIS; DROWSINESS; DRUG APPROVAL; DRUG EFFICACY; DRUG INDICATION; DYSTONIA; EMOTION; FOOD AND DRUG ADMINISTRATION; HEMATOTHORAX; HORNER SYNDROME; HUMAN; HYPERHIDROSIS; IONTOPHORESIS; MUSCLE WEAKNESS; MYDRIASIS; PAIN; PNEUMOTHORAX; PRIORITY JOURNAL; PSYCHOTHERAPY; RADIOTHERAPY; RECURRENT DISEASE; REVIEW; SIDE EFFECT; SKIN IRRITATION; SYMPATHECTOMY; WOUND INFECTION; XEROSTOMIA;

EID: 0036864847     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(02)00284-5     Document Type: Article

References (58)

1. Swinehart J.M. Treatment of axillary hyperhidrosis combination of the starch-iodine test with the tumescent liposuction technique . Dermatol Surg. 26:2000;392-396.
2. Heckmann M., Breit S., Ceballos-Baumann A., et al. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol. 41:1999;987-990.
3. Goldsmith LA. Disorders of the eccrine sweat gland. Freedberg IM, Eisen AZ, Wolff K, et al (Eds) in Fitzpatrick's Dermatology in General Medicine, 5th Edition. New York: McGraw-Hill, 1999:800-809.
4. Shelley W.B., Hurley H.J. Jr. Studies on topical antiperspirant control of axillary hyperhidrosis. Acta Dermato-Venereologica. 55:1075;241-260.
5. Quatrale R.P., Coble D.W., Stoner K.L., et al. The mechanism of antiperspirant action of aluminum salts. III. Histologic observations of human eccrine sweat glands inhibited by aluminum zirconium chlorohydrate glycine complex. J Soc Cosmet Chem. 32:1981;195-221.
6. Stolman L.P. Treatment of hyperhidrosis. Dermatol Clin. 16:1998;863-869.
7. Benohanian A., Dansereau A., Bolduc C., Bloom E. Localized hyperhidrosis treated with aluminum chloride in a salicylic acid gel base. Int J Dermatol. 37:1998;701-708.
8. Shelley W.B., Laskas J.J., Satanove A. Effect of topical agents on plantar sweating. Arch Dermatol. 69:1954;713-716.
9. Lukacs V.A., Korting H.C. Antitranspirantien und Deoderantien-Wirkstoffe und Berwertung. Derm Beruf Umwelt. 37:1989;53-57.
10. Seukeran D.C. The use of topical glycopyrrolate in the treatment of hyperhidrosis. Clin Exp Dermatol. 23:1998;204-205.
11. Kassan D.G. Physical enhancement of dermatologic drug delivery iontophoresis and phonophoresis . J Am Acad Dermatol. 34:1996;657-666.
12. Holze E., Ruzicka T. Treatment of hyperhidrosis by a battery-operated iontophoretic device. Dermatologica. 172:1986;41-47.
13. Abell E., Morgan K. The treatment of idiopathic hyperhidrosis by glycopyrronium bromide and tap water iontophoresis. Br J Dermatol. 91:1974;87-91.
14. Shen J.-L., Lin G.-S., Li W.-M. A new strategy of iontophoresis for hyperhidrosis. J Am Acad Dermatol. 22:1990;239-241.
15. Tashijian E.A., Richter K.J. The value of propoxyphene hydrochloride for the treatment of hyperhidrosis in the spinal cord injured patient an anecdotal experience and case reports . Paraplegia. 23:1985;349-353.
16. Anderson L.S., Biering-Sorenson F., Muller P.G., et al. The prevalence of hyperhidrosis in patients with spinal cord injuries and evaluation of the effect of dextropropoxyphene hydrochloride in therapy. Paraplegia. 30:1992;184-191.
17. Staas W.E., Nemuniatis G. Management of reflex sweating in spinal cord injured patients. Arch Phys Med Rehabil. 70:1989;544-546.
18. Garber A., Gregory R. Benztropine in the treatment of venlafaxine-induced sweating. J Clin Psychiatry. 58:1997;4176-4177.
19. Carson M.J., Montgomery T.A. Congenital hyperhidrosis, therapy with hydergine and banthine. J Pediatr. 43:1953;274-277.
20. Shessel F.S., Carrion H.M., Politano V.A. Phenoxybenzamine and sweating in the spinal cord injury patient. J Urol. 120:1978;60-61.
21. Feder R. Clonidine treatment of excessive sweating. J Clin Psychiatry. 56:1995;1. 35.
22. Khurana R.K. Orthostatic hypotension-induced autonomic dysreflexia. Neurology. 37:1987;1221-1224.
23. LeWitt P. Hyperhidrosis and hypothermia responsive to oxybutynin. Neurology. 38:1988;506-507.
24. Tkach J.R. Indomethacin treatment of generalized hyperhidrosis. J Am Acad Dermatol. 6:1982;545.
25. Goldyne M.E. Indomethacin and hyperhidrosis. J Am Acad Dermatol. 7:1982;801.
26. James W.D., Schoomaker M.C., Rodman M.C. Emotional eccrine sweating. Arch Dermatol. 123:1987;925-929.
27. Bar L.H.J., Kuypers B.R.M. Behavior therapy in dermatological practice. Br J Dermatol. 88:1973;591.
28. Duller P., Gentry W.D. Use of biofeedback in treating chronic hyperhidrosis a preliminary report . Br J Dermatol. 103:1980;143-146.
29. Drimmer E.J. Desensitization and benztropine for palmar hyperhidrosis. Psychosomatics. 26:1985;888-889.
30. Holze E. Therapie der hyperhidrosis. Hautarzt. 35:1994;7-15.
31. Shenefelt P.D. Hyposis in dermatology. Arch Dermatol. 136:2000;393-399.
32. Odderson I.R. Hyperhidrosis treated by botulinum A exotoxin. Dermatol Surg. 24:1998;1237-1241.
33. Naver H. Palmar and axillary hyperhidrosis treated with botulinum toxin one-year clinical follow-up . Eur J Neurol. 7:2000;55-62.
34. Schnider P. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol. 136:1997;548-552.
35. Heckmann M., Ceballos-Baumann A.O., Plewig G. Botulinum toxin A for axillary hyperhidrosis. N Engl J Med. 344:2001;488-493.
36. Naumann M., Lowe N.J. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis randomised, parallel group, double blind, placebo controlled trial . BMJ. 323:2001;596-599.
37. Solomon B.A., Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol. 42:2000;1026-1029.
38. Lange D.J., Brin M.F., Warner C.L., et al. Distant effects of local injection of botulinum toxin. Muscle Nerve. 10:1987;552-555.
39. Schnider P., Brichta A., Schmied M., Auff E. Gallbladder dysfunction induced by botulinum A toxin. Lancet. 342:1993;811-812.
40. Claus D., Druschy A., Erbguth F. Botulinum toxin influence on respiratory heart rate variation . Mov Disord. 10:1995;574-579.
41. Jankovic J., Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology. 45:1995;1743-1746.
42. Goschel H., Wohlfarth K., Frevert J., et al. Botulinum A toxin therapy neutralizing and nonneutralizing antibodies - therapeutic consequences . Exp Neurol. 147:1997;96-102.
43. Karamfilov T., Konrad H., Karte K., Wollina U. Lower relapse rate of botulinum toxin A for axillary hyperhidrosis by dose increase. Arch Dermatol. 126:2000;487-490.
44. de Almeida A.R., Kandunc B.V., de Oliveira E.M. Improving botulinum toxin therapy for palmar hyperhidrosis wrist block and technical considerations . Dermatol Surg. 27:2001;34-36.
45. Guttman C. Trial compares responses to Btx-A, Btx-B. Dermatol Times. 2002;60.
46. Park J.H., Cha S.H., Park S.D. Carbon dioxide laser treatment vs subcutaneous resection of axillary osmidrosis. Dermatol Surg. 23:1997;247-251.
47. 2 laser and subcutaneous tissue remover . Dermatol Surg. 25:1999;875-879.
48. Sung S.W. Ultra-thin needle thoracoscopic surgery for hyperhidrosis with excellent cosmetic effects. Eur J Cardiothorac Surg. 17:2000;691-696.
49. Fox A.D. The results of thoracoscopic sympathetic trunk transection for palmar hyperhidrosis and sympathetic ganglionectomy for axillary hyperhidrosis. Eur J Vasc Endovasc Surg. 17:1999;343-346.
50. Fukushima H., Makimura S., Takae H., et al. Endoscopic thoracic sympathectomy for palmar, axillary and palmar hyperhidrosis intermediate term results . Kyobu Geka - Japanese Journal of Thoracic Surgery. 54:2001;379-383.
51. Gossot D., Debrosse D., Grunenwald D. Endoscopic thoracic sympathectomy for isolated axillary hyperhidrosis. Annales de Dermatologie et de Venereologie. 127:2000;1065-1067.
52. Payne C.M., Doe P.T. Liposuction for axillary hyperhidrosis. Clin Exp Dermatol. 23:1998;9.
53. Shenaq S.M., Spira M., Christ J. Treatment of bilateral axillary hyperhidrosis by suction-assisted lipolysis technique. Ann Plast Surg. 19:1987;548-551.
54. Grazer F.M. A noninvasive surgical treatment of axillary hyperhidrosis. Clin Dermatol. 10:1992;357-364.
55. Tsai R.Y., Lin J.Y. Experience of tumescent liposuction in the treatment of osmidrosis. Dermatol Surg. 27:2001;446-448.
56. Park S. Very superficial ultrasound-assisted lipoplasty for the treatment of axillary osmidrosis. Aesthetic Plast Surg. 24:2000;275-279.
57. Coleman WP, Letessier S, Hanke CW. Liposuction (Chapter 12, 2nd ed.). Coleman WP, Hanke CW, Alt TH, and Asken S. (Editors), in Cosmetic Surgery of the Skin, Principles and Techniques. St. Louis: Mosby, 1997:203-205.
58. Hashmonai M., Kopelman D., Assalia A. The treatment of primary palmar hyperhidrosis a review . Surg Today. 30:2000;211-218.